Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review
- PMID: 33616740
- PMCID: PMC7897893
- DOI: 10.1007/s00415-021-10450-8
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review
Abstract
Background: Since the emergence of COVID-19 pandemic, several cases of cerebral venous sinus thrombosis (CVST) have been reported in SARS-CoV-2 infected individuals.
Methods: Consecutive patients with documented SARS-CoV-2 infection, as well as clinical and radiological characteristics of CVST, were reported from three teaching hospitals in the South West, North West, and the center of Iran between June and July 2020. We also searched the abstract archives until the end of August 2020 and gathered 28 reported cases. The diagnostic criteria for SARS-CoV-2 infection were determined according to SARS-CoV-2 detection in oropharyngeal or nasopharyngeal samples in clinically suspected patients. Demographics, prominent COVID-19 symptoms, confirmatory tests for SARS-CoV-2 infection diagnosis, the interval between the diagnosis of SARS-CoV-2 infection and CVST, clinical and radiological features of CVST, therapeutic strategies, CVST outcomes, rate of hemorrhagic transformation, and mortality rate were investigated.
Results: Six patients (31-62 years-old) with confirmed CVST and SARS-CoV-2 infection were admitted to our centers. Four patients had no respiratory symptoms of SARS-CoV-2 infection. Five patients developed the clinical manifestations of CVST and SARS-CoV-2 infection simultaneously. Three patients had known predisposing factors for CVST. Despite receiving CVST and SARS-CoV-2 infection treatments, four patients died. SARS-COV-2 associated CVST patients were older (49.26 vs. 37.77 years-old), had lower female/male ratio (1.42 vs. 2.19), and higher mortality rate (35.29% vs. 6.07%) than CVST not associated with COVID-19.
Conclusions: The role of SARS-CoV-2 as a "cause" versus an "additive contributor" remains to be elucidated. Practitioners should be aware of the possibility of CVST in SARS-CoV-2 infection.
Keywords: COVID-19; Coronavirus; Intracranial; SARS-CoV-2; Sinus thrombosis; Stroke.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series.J Neurol Sci. 2020 Dec 15;419:117183. doi: 10.1016/j.jns.2020.117183. Epub 2020 Oct 14. J Neurol Sci. 2020. PMID: 33075595 Free PMC article.
-
Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature.J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105412. doi: 10.1016/j.jstrokecerebrovasdis.2020.105412. Epub 2020 Oct 19. J Stroke Cerebrovasc Dis. 2020. PMID: 33254367 Free PMC article. Review.
-
Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.Neurology. 2021 Nov 23;97(21):e2136-e2147. doi: 10.1212/WNL.0000000000012896. Epub 2021 Oct 5. Neurology. 2021. PMID: 34610990
-
Deciphering changes in the incidence of hemorrhagic stroke and cerebral venous sinus thrombosis during the coronavirus disease 2019 pandemic: A nationwide time-series correlation study.PLoS One. 2024 Oct 3;19(10):e0301313. doi: 10.1371/journal.pone.0301313. eCollection 2024. PLoS One. 2024. PMID: 39361618 Free PMC article.
-
The Hospitalization Rate of Cerebral Venous Sinus Thrombosis before and during COVID-19 Pandemic Era: A Single-Center Retrospective Cohort Study.J Stroke Cerebrovasc Dis. 2022 Jul;31(7):106468. doi: 10.1016/j.jstrokecerebrovasdis.2022.106468. Epub 2022 Mar 25. J Stroke Cerebrovasc Dis. 2022. PMID: 35523051 Free PMC article.
Cited by
-
Successful endovascular mechanical thrombectomy in anticoagulation-resistant COVID-19 associated cerebral venous sinus thrombosis.BMJ Case Rep. 2021 Dec 31;14(12):e245405. doi: 10.1136/bcr-2021-245405. BMJ Case Rep. 2021. PMID: 34972772 Free PMC article. No abstract available.
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938. Blood. 2021. PMID: 34280256 Free PMC article.
-
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia.Trends Cardiovasc Med. 2022 Jan;32(1):1-9. doi: 10.1016/j.tcm.2021.08.012. Epub 2021 Aug 27. Trends Cardiovasc Med. 2022. PMID: 34455073 Free PMC article. Review.
-
Neuro-Ophthalmic Manifestation Associated With COVID-19 in a Tertiary Eye Center in Nepal.Case Rep Ophthalmol Med. 2025 Jul 26;2025:6694537. doi: 10.1155/crop/6694537. eCollection 2025. Case Rep Ophthalmol Med. 2025. PMID: 40757091 Free PMC article.
-
Long-Delayed Manifestation of COVID-19 Coagulopathy Presenting with Severe Cerebral Venous Thrombosis Causes Massive Brain Hemorrhage.Asian J Neurosurg. 2022 Aug 24;17(2):342-346. doi: 10.1055/s-0042-1750388. eCollection 2022 Jun. Asian J Neurosurg. 2022. PMID: 36120629 Free PMC article.
References
-
- Wasay M, Kaul S, Menon B, Dai AI, Saadatnia M, Malik A, et al (2019) Asian study of cerebral venous thrombosis. J Stroke Cerebrovasc Dis Off J Natil Stroke Assoc 28(10):104247 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous